What will Brexit mean for healthcare in the UK?

Since Britain voted to leave the EU, there has been much speculation on how this decision will affect the pharmaceutical industry and healthcare system within the country. Proponents of Brexit remain optimistic. However, there are [...]

By |2019-07-22T16:49:08+00:00February 16th, 2017|Big Pharma|

Adaptive Pathways

For many patients in the US, the passing of the 21st Century Cures Act was a great success. This new law will allow Real World Data (RWD) and patient experiences to be to be included [...]

By |2019-07-22T16:51:59+00:00February 8th, 2017|Big Pharma|

The importance of Real World Data

Upcoming US legislation, known as the 21st Century Cures Act, will incorporate more of the patient experience into drug development. There will be a focus on structured collection of data from patients about the personal [...]

By |2019-07-22T16:54:42+00:00February 2nd, 2017|Big Pharma|